Stoke Therapeutics, Inc. (NASDAQ:STOK) Shares Bought by JPMorgan Chase & Co.
JPMorgan Chase & Co. grew its holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 29.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,964 shares of the company’s stock after buying an additional 4,512 shares during the quarter. JPMorgan Chase […]
JPMorgan Chase & Co. grew its holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 29.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 19,964 shares of the company’s stock after buying an additional 4,512 shares during the quarter. JPMorgan Chase […]
